3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
102
Neoplasms, Plasma Cell
12
Recurrence
9
Lymphoma
8
Immunoglobulin Light-chain Amyloidosis
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
5
Neoplasms
5
Leukemia, Myeloid, Acute
5
Lymphoma, Mantle-Cell
4
Waldenstrom Macroglobulinemia
3
Paraproteinemias
3
Hematologic Neoplasms
3
Amyloidosis
3
Renal Insufficiency
2
Myelodysplastic Syndromes
2
Lymphoproliferative Disorders
2
Lymphoma, T-Cell
2
Burkitt Lymphoma
2
beta-Thalassemia
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Thalassemia
1
Sarcoma, Myeloid
1
Prostatic Neoplasms
1
Plasmacytoma
1
Plasmablastic Lymphoma
1
Peripheral Nervous System Diseases
1
Interventions
pembrolizumab
4
lenvatinib
3
Magnetic Resonance Spectroscopy
3
Specimen Handling
2
Nivolumab
2
Epirubicin
2
regorafenib
1
gallium 68 PSMA-11
1
enfortumab vedotin
1
anlotinib
1
amivantamab
1
abemaciclib
1
Tablets
1
Surveys and Questionnaires
1
Standard of Care
1
Radiosurgery
1
Pemetrexed
1
Observation
1
Ipilimumab
1
Imatinib Mesylate
1
Glutamate Carboxypeptidase II
1
Cyclophosphamide
1
Combined Modality Therapy
1
Carboplatin
1
CTLA-4 Antigen
1
Blood Specimen Collection
1
BMS-906024
1
68Ga-DKFZ-PSMA-11
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Adenoid Cystic
×
Bortezomib
×
1 year
×
Clear all
No trials found.